Precursor of multiple myeloma more common in blacks than whites, Mayo study finds

Blacks may be twice as likely as whites to develop multiple myeloma because they are also more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance.

Mayo Clinic Discovers African-Americans Respond Better to Rubella Vaccine

Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians.

Advancements in multiple sclerosis research hold promise for patients

Dean M. Wingerchuk, M.D., neurologist at Mayo Clinic's campus in Arizona, explains how the future holds promise for multiple sclerosis research.

Minority disparities evident in prostate cancer survival rate, Mayo Clinic study shows

A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk of poorer survival rate following prostate cancer treatment compared with other minority groups.

Fibromyalgia treatment research

Terry H. Oh, M.D., Mayo Clinic associate professor of PM&R, discusses fibromyalgia research that was conducted with a database created from patients seen in the Fibromyalgia Treatment Program.

CREST-2 trial: Determining the best treatment for carotid atherosclerotic stenosis

Kevin M. Barrett, M.D., vascular neurologist at Mayo Clinic's campus in Florida, talks about the second phase of the international stroke trial and how to refer patients for participation. Dr. Barrett shares information about the seven-year ...